Qisheng Biological Preparation Co., Ltd. Report issue

For profit Phase 4
Founded: Minhang China (2010)
Status: Defunct (2013)

Organization Overview

First Clinical Trial
2014
NCT02323451
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

chitosan (1 trial)

hyaluronic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2